SouthCoast Research Center, Inc.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)3 trials
• Chronic kidney disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Viatris Innovation GmbH2 trials
• AION Healthspan, Inc.1 trial
• Biocon Limited1 trial
• InDex Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)

  NCT06721143· Phase 1/2· AION Healthspan, Inc.· Source

  Contact: Oleg Leon-Pimentel, MD

• Enrolling by invitation

  Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT06475742· Phase 3· Viatris Innovation GmbH· Source

• Active, not recruiting

  A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT05648500· Phase 3· Viatris Innovation GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Lupus (SLE)1 recruiting

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

  NCT04128579· Phase 1· Biocon Limited· Source